MarketCapExport financials
Allscripts Healthcare Solutions (MDRX)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Allscripts Healthcare Solutions Income Statement 2024-2007 | MDRX
Brief overview of income trends at Allscripts Healthcare Solutions
This overview is based on financial performance over the past five years. Revenue reported by Allscripts Healthcare Solutions was 1.8 billion dollars at the beginning of the period and 594 million dollars at the end. The cumulative result was −66.4%, corresponding to roughly −19.6% per year. The decline points to a contraction in the scale of the business.
At the gross-profit level, the result moved from 714 million dollars to 302 million dollars, a change of −57.6%. Revenue and direct costs changed at similar rates. Gross profit as a share of revenue changed from 40.3% to 50.8%. A wider margin shows that the economics of the core business improved.
The five-year EBITDA result moved by −478.9%: from 39.3 million dollars to −149 million dollars. EBITDA lagged revenue, showing weaker operating momentum. At the operating-margin level, the figure shifted from 2.2% to −25%. The margin contraction indicates weaker operating efficiency.
The net financial result changed from −182 million dollars to −292 million dollars. The loss widened and increased the financial risk.
Financial takeaway
The results contain several connected negative signals. The positive side is supported by improving gross profitability. The main areas of concern are a narrow EBITDA buffer, limited revenue growth and a declining EBITDA margin. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Allscripts Healthcare Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | - | 2.4 B | 2.3 B | 1.49 B | 2.06 B | 2.73 B | 2.14 B | 2.55 B | 2.14 B | 2.95 B | 2.01 B | 3.56 B | 3.07 B | 1.94 B | - | - |
Shares |
108 M | 107 M | 112 M | 130 M | 159 M | 166 M | 176 M | 181 M | 186 M | 185 M | 180 M | 177 M | 179 M | 189 M | 168 M | 144 M | - | - |
Historical Prices |
- | - | - | 18.4 | 14.4 | 9.82 | 9.64 | 14.6 | 10.2 | 15.4 | 12.8 | 15.5 | 9.42 | 18.9 | 18.3 | 13.4 | 12.2 | 24.8 |
Net Income |
-292 M | 49.2 M | -86.5 M | 73.5 M | 696 M | -182 M | 364 M | -196 M | -25.7 M | -2.23 M | -66.5 M | -104 M | -1.15 M | 73.6 M | -5.56 M | 30.5 M | 25.4 M | - |
Revenue |
594 M | 626 M | 588 M | 157 M | 556 M | 1.77 B | 1.75 B | 1.81 B | 1.55 B | 1.39 B | 1.38 B | 1.37 B | 1.45 B | 1.44 B | 613 M | 383 M | 384 M | - |
Cost of Revenue |
292 M | 284 M | 280 M | 73.8 M | 292 M | 1.02 B | 996 M | 865 M | 785 M | 806 M | 832 M | 839 M | 840 M | 28.1 M | 315 M | 174 M | 177 M | - |
Gross Profit |
302 M | 342 M | 308 M | 83.4 M | 264 M | 714 M | 725 M | 782 M | 671 M | 581 M | 546 M | 534 M | 607 M | 666 M | 298 M | 210 M | 207 M | - |
Operating Income |
-195 M | 34.7 M | -27.1 M | 35.2 M | 7.94 M | -99.7 M | -168 M | 12.5 M | 67.7 M | 31.9 M | -39.2 M | -128 M | 13.3 M | 137 M | 5.88 M | 50.1 M | 40.2 M | - |
Interest Expense |
15 M | 5.29 M | 6.35 M | 3.46 M | 34.3 M | 43.2 M | 50.9 M | 37.5 M | 29.5 M | 31.4 M | 29.3 M | 28.1 M | 16.2 M | 20.8 M | 9.69 M | 1.3 M | 296 K | - |
EBITDA |
-149 M | 87.3 M | 86.5 M | 108 M | 95.1 M | 39.3 M | 5.17 M | 75.7 M | 90.3 M | 56.6 M | -5.52 M | -84.9 M | 60 M | 174 M | 56 M | 72.9 M | 56.4 M | - |
Operating Expenses |
- | - | - | - | 622 M | 701 M | 746 M | 740 M | 607 M | 547 M | 583 M | 651 M | 582 M | 529 M | - | - | - | - |
General and Administrative Expenses |
269 M | 201 M | 169 M | 24.6 M | 156 M | 420 M | 451 M | 486 M | 393 M | 339 M | 359 M | 420 M | 384 M | 388 M | 233 M | 127 M | 118 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Allscripts Healthcare Solutions
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 110 M | 114 M | 116 M | 116 M | 124 M | 137 M | 140 M | 140 M | 161 M | 163 M | 162 M | 162 M | 166 M | 167 M | 170 M | 171 M | 175 M | 176 M | 180 M | 181 M | 181 M | 181 M | 181 M | 181 M | 186 M | 187 M | 189 M | 189 M | 189 M | 182 M | 181 M | 180 M | 180 M | 180 M | 179 M | 179 M | 178 M | 178 M | 174 M | 172 M | 171 M | 182 M | 191 K | 190 M | 188 M | 190 M | 190 M | 186 M |
Net Income |
- | 14.5 M | -64 M | 22.9 M | - | 16.2 M | 21.9 M | 9.06 M | 728 M | 542 K | -7.6 M | -20.4 M | -19 M | -5.72 M | -150 M | -7.98 M | 386 M | -23.8 M | 74.3 M | -28.5 M | 14.9 M | -17.5 M | -143 M | -20 M | -7.31 M | -10.2 M | -10.2 M | 2.05 M | 16.3 M | -5.24 M | -3.22 M | -10.1 M | -2.18 M | -25.8 M | -17.8 M | -20.7 M | -20.6 M | -48.9 M | -22.9 M | -11.6 M | - | 9.38 M | 7.98 M | 5.81 M | - | 21 M | 15.9 M | 12.6 M | 1.37 M |
Revenue |
- | 152 M | 151 M | 143 M | 392 M | 369 M | 374 M | 368 M | 386 M | 402 M | 406 M | 417 M | 414 M | 444 M | 444 M | 432 M | 442 M | 522 M | 526 M | 514 M | 517 M | 449 M | 426 M | 413 M | 425 M | 392 M | 387 M | 346 M | 346 M | 354 M | 352 M | 335 M | 341 M | 345 M | 351 M | 340 M | 351 M | 330 M | 345 M | 347 M | - | 361 M | 370 M | 365 M | - | 369 M | 357 M | 335 M | 242 M |
Cost of Revenue |
- | 68.5 M | 71.4 M | 69.2 M | - | 220 M | 222 M | 218 M | 225 M | 240 M | 242 M | 260 M | 262 M | 269 M | 260 M | 258 M | 254 M | 304 M | 313 M | 293 M | 260 M | 248 M | 239 M | 235 M | 239 M | 226 M | 220 M | 194 M | 192 M | 201 M | 208 M | 205 M | 205 M | 214 M | 211 M | 202 M | 213 M | 205 M | 209 M | 213 M | - | 204 M | 212 M | 209 M | - | 10 M | 5 M | 175 M | 118 M |
Gross Profit |
- | 83.4 M | 79.5 M | 73.5 M | - | 149 M | 152 M | 150 M | 161 M | 162 M | 164 M | 157 M | 153 M | 175 M | 184 M | 174 M | 188 M | 218 M | 213 M | 221 M | 176 M | 202 M | 187 M | 179 M | 186 M | 166 M | 167 M | 152 M | 154 M | 153 M | 144 M | 130 M | 136 M | 131 M | 140 M | 138 M | 138 M | 126 M | 136 M | 134 M | - | 157 M | 157 M | 156 M | - | 167 M | 168 M | 160 M | 124 M |
Operating Income |
- | 25 M | -5.36 M | 6.57 M | - | 12.1 M | 10.4 M | 13.3 M | -68.1 M | 9.38 M | -4.75 M | -9.2 M | -55.1 M | 3.18 M | 4.74 M | 2.64 M | -26.4 M | 2.41 M | -58.8 M | -4.32 M | -21.3 M | 25.4 M | 21.1 M | 11.3 M | 12.4 M | 16.9 M | 18.6 M | 11.9 M | 23.1 M | 8.87 M | 5.59 M | -5.7 M | 656 K | -18.8 M | -9.09 M | -11.9 M | -27.5 M | -43.5 M | -28.3 M | -28.3 M | - | 9.18 M | 17.7 M | 13 M | - | 37.4 M | 32.1 M | 24.5 M | -1.69 M |
Interest Expense |
- | 1.25 M | 1.89 M | 2.14 M | - | 3.62 M | 2.95 M | 3.14 M | 6.46 M | 7.66 M | 11.4 M | 12.2 M | 11.7 M | 10.8 M | 10.4 M | 10.2 M | 14 M | 29.3 M | 26.5 M | 25 M | 11.6 M | 22.3 M | 20.3 M | 20.2 M | 25.4 M | -6 K | 106 K | 366 K | -98 K | 423 K | 148 K | 7.26 M | 7.29 M | 7.54 M | 7.23 M | 7.23 M | 7.02 M | 6.9 M | 9.5 M | 4.64 M | - | 3.72 M | 4.36 M | 3.85 M | - | 3.75 M | 5.05 M | 7.93 M | 3.07 M |
EBITDA |
- | 67.3 M | 23.1 M | 20.7 M | - | 145 M | 99.1 M | 57.4 M | -68.1 M | 163 M | 99.8 M | 42.9 M | -55.1 M | 155 M | 105 M | 52.8 M | -19.5 M | 203 M | 73.4 M | 61.6 M | -15.3 M | 180 M | 122 M | 61 M | 23.3 M | 137 M | 95.2 M | 46.3 M | 27.3 M | 133 M | 89.1 M | 36 M | 9.52 M | 113 M | 79.6 M | 33.2 M | -19.9 M | 88.3 M | 56.6 M | 12.5 M | - | 120 M | 90.6 M | 48.2 M | - | 135 M | 95.8 M | 55.3 M | 34.3 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 352 M | - | - | - | 311 M | - |
General and Administrative Expenses |
- | 32.5 M | 59.8 M | 41.3 M | - | 78.8 M | 79.1 M | 81.7 M | 93.8 M | 97.2 M | 115 M | 97.3 M | 108 M | 101 M | 106 M | 100 M | 100 M | 133 M | 149 M | 143 M | 123 M | 117 M | 112 M | 111 M | 115 M | 98.8 M | 94.8 M | 84.2 M | 79.4 M | 91 M | 86.7 M | 82 M | 85 M | 97 M | 86.7 M | 89.9 M | 109 M | 105 M | 104 M | 104 M | - | 90.4 M | 92.3 M | 97.3 M | - | 94.1 M | 102 M | 104 M | 104 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Allscripts Healthcare Solutions (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B |  USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 9.34 | -1.37 % | $ 173 M | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
10x Genomics
TXG
|
$ 62.88 | -3.34 % | $ 7.84 B | USA |
 |
Veeva Systems
VEEV
|
$ 306.1 | -0.1 % | $ 50.1 B | USA |
 |
SCWorx Corp.
WORX
|
$ 1.31 | -5.76 % | $ 9.53 M | USA |
 |
Zhongchao
ZCMD
|
$ 0.94 | -5.99 % | $ 3.21 M |  China |
 |
HealthStream
HSTM
|
$ 28.69 | -0.14 % | $ 861 M | USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
So-Young International
SY
|
$ 2.0 | 0.5 % | $ 156 M | China |
 |
American Well Corporation
AMWL
|
$ 12.0 | -3.73 % | $ 193 M | USA |
 |
Evolent Health
EVH
|
$ 4.79 | 1.7 % | $ 547 M | USA |
 |
GoodRx Holdings
GDRX
|
$ 3.54 | -3.01 % | $ 1.26 B | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Health Catalyst
HCAT
|
$ 1.46 | -3.31 % | $ 102 M | USA |
 |
HealthEquity
HQY
|
$ 103.68 | 1.53 % | $ 8.93 B | USA |
 |
Omnicell
OMCL
|
$ 35.87 | -3.96 % | $ 1.65 B | USA |
 |
Progyny
PGNY
|
$ 36.44 | 1.35 % | $ 3.11 B | USA |
 |
Schrödinger
SDGR
|
$ 32.42 | -2.89 % | $ 2.38 B | USA |
 |
Teladoc Health
TDOC
|
$ 8.96 | -0.28 % | $ 1.58 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Phreesia
PHR
|
$ 13.15 | 1.94 % | $ 786 M | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |